ROYCE & ASSOCIATES LP - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 72 filers reported holding TRANSMEDICS GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$7,757,966
-32.8%
141,698
+3.1%
0.08%
-29.5%
Q2 2023$11,547,250
-4.4%
137,500
-13.8%
0.11%
-7.4%
Q1 2023$12,078,935
+1.9%
159,500
-16.9%
0.12%
-3.2%
Q4 2022$11,850,240
+86.8%
192,000
+26.3%
0.12%
+73.6%
Q3 2022$6,344,000
+42.1%
152,000
+7.0%
0.07%
+56.5%
Q2 2022$4,466,000
+90.5%
142,000
+63.2%
0.05%
+130.0%
Q1 2022$2,344,000
+100.5%
87,000
+42.6%
0.02%
+122.2%
Q4 2021$1,169,000
+106.9%
61,000
+48.8%
0.01%
+50.0%
Q3 2020$565,00041,0000.01%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2020
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders